10-Q Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 Q1 2025

Filing Information

Form Type	10-Q
Accession Number	`0001628280-25-004634`
Period End Date	20241231
Filing Date	20250210
Fiscal Year	2025
Fiscal Period	Q1
XBRL Instance	arwr-20241231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 150 Income Statement 84 Cash Flow Statement 128 Stockholders Equity 40

Balance Sheet 150 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	290.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	290.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	290.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	290.00M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	124.38M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	124.38M	shares	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$53.89M	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$53.89M	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$102.69M	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$102.69M	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$110.89M	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$110.89M	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$58.22M	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$58.22M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	125.57M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	125.57M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	125.57M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	125.57M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	124.38M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	124.38M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	-	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	-	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$2.50M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$2.50M	USD	Point-in-time
Available-for-sale securities, at fair value	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$578.28M	USD	Point-in-time
Available-for-sale securities, at fair value	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$578.28M	USD	Point-in-time
Available-for-sale securities, at fair value	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$499.05M	USD	Point-in-time
Available-for-sale securities, at fair value	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$499.05M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$9.37M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$9.37M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$9.54M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$9.54M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$4.97M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$4.97M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$5.74M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$5.74M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$570.54M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$570.54M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$695.47M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$695.47M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$387.07M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$387.07M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$386.03M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$386.03M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$8.56M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$8.56M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$8.14M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$8.14M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$45.26M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$45.26M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$44.87M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$44.87M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$3.08M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$3.08M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.48M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.48M	USD	Point-in-time
Total Assets	`Assets`	$1.01B	USD	Point-in-time
Total Assets	`Assets`	$1.01B	USD	Point-in-time
Total Assets	`Assets`	$1.14B	USD	Point-in-time
Total Assets	`Assets`	$1.14B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$14.46M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$14.46M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$11.39M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$11.39M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$59.40M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$59.40M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$63.02M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$63.02M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$21.99M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$21.99M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$11.28M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$11.28M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$6.34M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$6.34M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$6.56M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$6.56M	USD	Point-in-time
Credit facility	`LinesOfCreditCurrent`	-	USD	Point-in-time
Credit facility	`LinesOfCreditCurrent`	-	USD	Point-in-time
Credit facility	`LinesOfCreditCurrent`	$1.62M	USD	Point-in-time
Credit facility	`LinesOfCreditCurrent`	$1.62M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesCurrent`	$432.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesCurrent`	$432.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesCurrent`	$440.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesCurrent`	$440.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$93.76M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$93.76M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$103.17M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$103.17M	USD	Point-in-time
Lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$109.30M	USD	Point-in-time
Lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$109.30M	USD	Point-in-time
Lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$111.03M	USD	Point-in-time
Lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$111.03M	USD	Point-in-time
Liability related to the sale of future royalties	`RoyaltiesLiabilityNoncurrent`	$268.33M	USD	Point-in-time
Liability related to the sale of future royalties	`RoyaltiesLiabilityNoncurrent`	$268.33M	USD	Point-in-time
Liability related to the sale of future royalties	`RoyaltiesLiabilityNoncurrent`	$346.78M	USD	Point-in-time
Liability related to the sale of future royalties	`RoyaltiesLiabilityNoncurrent`	$346.78M	USD	Point-in-time
Liability related to the sale of future royalties	`RoyaltiesLiabilityNoncurrent`	$341.36M	USD	Point-in-time
Liability related to the sale of future royalties	`RoyaltiesLiabilityNoncurrent`	$341.36M	USD	Point-in-time
Credit facility, net of current portion	`LongTermLineOfCredit`	$393.18M	USD	Point-in-time
Credit facility, net of current portion	`LongTermLineOfCredit`	$393.18M	USD	Point-in-time
Credit facility, net of current portion	`LongTermLineOfCredit`	$407.79M	USD	Point-in-time
Credit facility, net of current portion	`LongTermLineOfCredit`	$407.79M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$845.57M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$845.57M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$863.86M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$863.86M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value: Authorized 290,000 shares; issued and outstanding 125,572 and 124,376 shares	`CommonStockValue`	$218.00K	USD	Point-in-time
Common stock, $0.001 par value: Authorized 290,000 shares; issued and outstanding 125,572 and 124,376 shares	`CommonStockValue`	$218.00K	USD	Point-in-time
Common stock, $0.001 par value: Authorized 290,000 shares; issued and outstanding 125,572 and 124,376 shares	`CommonStockValue`	$217.00K	USD	Point-in-time
Common stock, $0.001 par value: Authorized 290,000 shares; issued and outstanding 125,572 and 124,376 shares	`CommonStockValue`	$217.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.81B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.81B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.85B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.85B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$4.14M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$4.14M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$4.75M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$4.75M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.80B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.80B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.63B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.63B	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders equity	`StockholdersEquity`	$185.44M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders equity	`StockholdersEquity`	$185.44M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders equity	`StockholdersEquity`	$52.59M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders equity	`StockholdersEquity`	$52.59M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$3.49M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$3.49M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$5.62M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$5.62M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$191.06M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$191.06M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$287.16M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$287.16M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$173.71M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$173.71M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$56.08M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$56.08M	USD	Point-in-time
Total Liabilities, Noncontrolling Interest and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$1.14B	USD	Point-in-time
Total Liabilities, Noncontrolling Interest and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$1.14B	USD	Point-in-time
Total Liabilities, Noncontrolling Interest and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$1.01B	USD	Point-in-time
Total Liabilities, Noncontrolling Interest and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$1.01B	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.50M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.50M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.55M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.55M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$137.00M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$137.00M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$116.49M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$116.49M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$26.91M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$26.91M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$23.61M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$23.61M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$163.91M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$163.91M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$140.10M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$140.10M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-136.54M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-136.54M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-161.41M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-161.41M	USD	1 Quarter
Interest income	`InvestmentIncomeInterestAndDividend`	$2.80M	USD	1 Quarter
Interest income	`InvestmentIncomeInterestAndDividend`	$2.80M	USD	1 Quarter
Interest income	`InvestmentIncomeInterestAndDividend`	$7.60M	USD	1 Quarter
Interest income	`InvestmentIncomeInterestAndDividend`	$7.60M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$5.37M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$5.37M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$21.65M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$21.65M	USD	1 Quarter
Other, net	`OtherNonoperatingIncomeExpense`	$341.00K	USD	1 Quarter
Other, net	`OtherNonoperatingIncomeExpense`	$341.00K	USD	1 Quarter
Other, net	`OtherNonoperatingIncomeExpense`	$421.00K	USD	1 Quarter
Other, net	`OtherNonoperatingIncomeExpense`	$421.00K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-2.14M	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-2.14M	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-13.70M	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-13.70M	USD	1 Quarter
Loss before income tax expense and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-175.12M	USD	1 Quarter
Loss before income tax expense and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-175.12M	USD	1 Quarter
Loss before income tax expense and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-138.69M	USD	1 Quarter
Loss before income tax expense and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-138.69M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$103.00K	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$103.00K	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-3.31M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-3.31M	USD	1 Quarter
Net loss including noncontrolling interest	`ProfitLoss`	$-135.38M	USD	1 Quarter
Net loss including noncontrolling interest	`ProfitLoss`	$-135.38M	USD	1 Quarter
Net loss including noncontrolling interest	`ProfitLoss`	$-175.22M	USD	1 Quarter
Net loss including noncontrolling interest	`ProfitLoss`	$-175.22M	USD	1 Quarter
Net loss attributable to noncontrolling interest, net of tax	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.51M	USD	1 Quarter
Net loss attributable to noncontrolling interest, net of tax	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.51M	USD	1 Quarter
Net loss attributable to noncontrolling interest, net of tax	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.13M	USD	1 Quarter
Net loss attributable to noncontrolling interest, net of tax	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.13M	USD	1 Quarter
Net loss attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$-173.09M	USD	1 Quarter
Net loss attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$-173.09M	USD	1 Quarter
Net loss attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$-132.86M	USD	1 Quarter
Net loss attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$-132.86M	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-1.24	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-1.24	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-1.39	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-1.39	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.39	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.39	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.24	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.24	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	124.85M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	124.85M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	107.42M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	107.42M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	124.85M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	124.85M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	107.42M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	107.42M	shares	1 Quarter
Unrealized (losses) gains on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$1.91M	USD	1 Quarter
Unrealized (losses) gains on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$1.91M	USD	1 Quarter
Unrealized (losses) gains on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-507.00K	USD	1 Quarter
Unrealized (losses) gains on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-507.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$58.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$58.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-106.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-106.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-133.41M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-133.41M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-175.83M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-175.83M	USD	1 Quarter

Cash Flow Statement 128 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-135.38M	USD	1 Quarter
Net loss	`ProfitLoss`	$-135.38M	USD	1 Quarter
Net loss	`ProfitLoss`	$-175.22M	USD	1 Quarter
Net loss	`ProfitLoss`	$-175.22M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$19.69M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$19.69M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$15.21M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$15.21M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$5.24M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$5.24M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$4.26M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$4.26M	USD	1 Quarter
Accretion of note premiums/discounts	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$5.70M	USD	1 Quarter
Accretion of note premiums/discounts	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$5.70M	USD	1 Quarter
Accretion of note premiums/discounts	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$835.00K	USD	1 Quarter
Accretion of note premiums/discounts	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$835.00K	USD	1 Quarter
Realized loss on investments	`RealizedInvestmentGainsLosses`	-	USD	1 Quarter
Realized loss on investments	`RealizedInvestmentGainsLosses`	-	USD	1 Quarter
Realized loss on investments	`RealizedInvestmentGainsLosses`	$80.00K	USD	1 Quarter
Realized loss on investments	`RealizedInvestmentGainsLosses`	$80.00K	USD	1 Quarter
Non-cash interest expense on liability related to the sale of future royalties	`NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties`	$5.42M	USD	1 Quarter
Non-cash interest expense on liability related to the sale of future royalties	`NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties`	$5.42M	USD	1 Quarter
Non-cash interest expense on liability related to the sale of future royalties	`NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties`	$5.37M	USD	1 Quarter
Non-cash interest expense on liability related to the sale of future royalties	`NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties`	$5.37M	USD	1 Quarter
Non-cash interest expense on liability related to the sale of future royalties	`NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties`	$23.04M	USD	Annual
Non-cash interest expense on liability related to the sale of future royalties	`NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties`	$23.04M	USD	Annual
Non-cash interest expense on credit facility	`PaidInKindInterest`	$16.23M	USD	1 Quarter
Non-cash interest expense on credit facility	`PaidInKindInterest`	$16.23M	USD	1 Quarter
Non-cash interest expense on credit facility	`PaidInKindInterest`	-	USD	1 Quarter
Non-cash interest expense on credit facility	`PaidInKindInterest`	-	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$2.50M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$2.50M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.75M	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.75M	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$592.00K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$592.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.07M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.07M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-12.46M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-12.46M	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-7.69M	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-7.69M	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$408.00K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$408.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-866.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-866.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	-	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	-	USD	1 Quarter
Operating lease, net	`IncreaseDecreaseInOperatingLeaseLiability`	$3.80M	USD	1 Quarter
Operating lease, net	`IncreaseDecreaseInOperatingLeaseLiability`	$3.80M	USD	1 Quarter
Operating lease, net	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.13M	USD	1 Quarter
Operating lease, net	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.13M	USD	1 Quarter
Other	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-1.40M	USD	1 Quarter
Other	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-1.40M	USD	1 Quarter
Other	`IncreaseDecreaseInOtherOperatingCapitalNet`	-	USD	1 Quarter
Other	`IncreaseDecreaseInOtherOperatingCapitalNet`	-	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-117.84M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-117.84M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-146.27M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-146.27M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$7.52M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$7.52M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$68.66M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$68.66M	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$33.75M	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$33.75M	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	-	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	-	USD	1 Quarter
Proceeds from sales and maturities of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$118.17M	USD	1 Quarter
Proceeds from sales and maturities of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$118.17M	USD	1 Quarter
Proceeds from sales and maturities of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$133.50M	USD	1 Quarter
Proceeds from sales and maturities of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$133.50M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$76.91M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$76.91M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$64.84M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$64.84M	USD	1 Quarter
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$267.00K	USD	1 Quarter
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$267.00K	USD	1 Quarter
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$634.00K	USD	1 Quarter
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$634.00K	USD	1 Quarter
Proceeds from the issuance of pre-funded warrants	`ProceedsFromIssuanceOfWarrants`	-	USD	1 Quarter
Proceeds from the issuance of pre-funded warrants	`ProceedsFromIssuanceOfWarrants`	-	USD	1 Quarter
Proceeds from the issuance of pre-funded warrants	`ProceedsFromIssuanceOfWarrants`	$25.00M	USD	Point-in-time
Proceeds from the issuance of pre-funded warrants	`ProceedsFromIssuanceOfWarrants`	$25.00M	USD	Point-in-time
Proceeds from the issuance of pre-funded warrants	`ProceedsFromIssuanceOfWarrants`	$25.00M	USD	1 Quarter
Proceeds from the issuance of pre-funded warrants	`ProceedsFromIssuanceOfWarrants`	$25.00M	USD	1 Quarter
Payments of debt issuance cost	`PaymentsOfDebtIssuanceCosts`	-	USD	1 Quarter
Payments of debt issuance cost	`PaymentsOfDebtIssuanceCosts`	-	USD	1 Quarter
Payments of debt issuance cost	`PaymentsOfDebtIssuanceCosts`	$5.00M	USD	1 Quarter
Payments of debt issuance cost	`PaymentsOfDebtIssuanceCosts`	$5.00M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$20.63M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$20.63M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$267.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$267.00K	USD	1 Quarter
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-48.73M	USD	1 Quarter
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-48.73M	USD	1 Quarter
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-52.73M	USD	1 Quarter
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-52.73M	USD	1 Quarter
Effect of exchange rate on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$58.00K	USD	1 Quarter
Effect of exchange rate on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$58.00K	USD	1 Quarter
Effect of exchange rate on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-68.00K	USD	1 Quarter
Effect of exchange rate on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-68.00K	USD	1 Quarter
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$53.89M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$53.89M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$102.69M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$102.69M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$110.89M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$110.89M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$58.22M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$58.22M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$53.89M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$53.89M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$102.69M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$102.69M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$110.89M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$110.89M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$58.22M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$58.22M	USD	Point-in-time
Income taxes paid	`IncomeTaxesPaidNet`	$-999.00K	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$-999.00K	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$-11.00K	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$-11.00K	USD	1 Quarter
Capital expenditures included in accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$2.57M	USD	1 Quarter
Capital expenditures included in accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$2.57M	USD	1 Quarter
Capital expenditures included in accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$11.29M	USD	1 Quarter
Capital expenditures included in accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$11.29M	USD	1 Quarter

Stockholders Equity 40 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$191.06M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$191.06M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$287.16M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$287.16M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$173.71M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$173.71M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$56.08M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$56.08M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$19.69M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$19.69M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$15.21M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$15.21M	USD	1 Quarter
Exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	69,506.00	shares	1 Quarter
Exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	69,506.00	shares	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$634.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$634.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$267.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$267.00K	USD	1 Quarter
Pre-funded warrants	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$25.00M	USD	1 Quarter
Pre-funded warrants	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$25.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$58.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$58.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-106.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-106.00K	USD	1 Quarter
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$1.91M	USD	1 Quarter
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$1.91M	USD	1 Quarter
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-507.00K	USD	1 Quarter
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-507.00K	USD	1 Quarter
Net loss	`ProfitLoss`	$-135.38M	USD	1 Quarter
Net loss	`ProfitLoss`	$-135.38M	USD	1 Quarter
Net loss	`ProfitLoss`	$-175.22M	USD	1 Quarter
Net loss	`ProfitLoss`	$-175.22M	USD	1 Quarter
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$191.06M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$191.06M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$287.16M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$287.16M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$173.71M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$173.71M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$56.08M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$56.08M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.